Manufacture of microscopic silk-protein capsules on a polymer chip; viewed with an ultra-fast Phantom camera taking 700,000 pictures per second. ©2017 Knowles Group
Microfluidics technology enables silk protein capsules to self-assemble; the cocoons could be used in the medical, cosmetic, and food industries
Scientists have managed to design microscopic silk capsules that mimic, on a very small scale, the structure of silkworm cocoons. The capsules can serve as a protective environment for the transport of sensitive “cargo” such as natural silk proteins, antibodies, or other delicate molecules. The collaborative research – which was performed by an international team of academics from the Weizmann Institute of Science in Israel; the Universities of Cambridge, Oxford, and Sheffield in the UK; and the ETH in Switzerland – may lead to a host of applications in the cosmetics, food, and pharmaceutical industries, particularly in the delivery of drugs within the body. The findings were reported in Nature Communications.
The use of natural proteins from which silkworms and spiders spin their elastic fibers has been limited, as these proteins have a tendency to clump together once extracted. Until now, researchers have been using chemically processed silk fibers, which have different mechanical properties and are relatively inert compared to the natural ones. Dr. Ulyana Shimanovich – then a postdoctoral fellow supervised by Prof. Tuomas P.J. Knowles at the University of Cambridge, and now head of a new lab in Weizmann’s Department of Materials and Interfaces– decided to find out what keeps the natural silk proteins from clumping together in the animal prior to the spinning.
The silk proteins are stored in liquid form in the silkworm’s glands before they are spun into the threads used to construct the cocoons. To imitate the natural process of structuring silk protein into protective capsules, the researchers used the principles of microfluidics, a field that deals with the control of fluid flow parameters on the micron-scale level. They placed proteins extracted directly from the glands of silkworms inside microscopic channels on a chip made of a silicon-derived polymer and caused the protein molecules to self-assemble into a gel-like material, exactly as in a silkworm. The gel formed microscopic capsules; within these capsules the rest of the protein stayed protected as a solution, as it does in the animal’s gland. By controlling the viscosity of the silk protein solution and the forces acting upon it, the researchers have been able to control the capsules’ shape – round or elongated – and size: from 300 nanometers to more than 20 micrometers. Inside these artificial capsules, the natural silk proteins remained intact for an unlimited amount of time without losing their properties or ability to function.
Dr. Shimanovich explains: “Making synthetic capsules is normally a complex and energy-intensive process. In contrast, silk capsules are easier to produce and require less energy to manufacture. Moreover, silk is biodegradable.”
The tough silk capsules may be used to protect sensitive molecules, such as antibodies and other proteins, preventing them from losing desired qualities. The capsules can be employed, for example, to deliver drugs or vaccines intact to target organs. In particular, says Dr. Shimanovich, they may help develop future therapies for neurodegenerative diseases: Because the capsules can penetrate the blood-brain barrier, they may enable the development of new treatment for these diseases.
A silkworm viewed with an infrared camera. The pale, elongated cavity is the silk gland. ©2017 Natural Materials Group
And because the capsules are biodegradable, they may have multiple uses. For example, they might be employed in the food industry to incorporate healthful oil particles into bread or other products. Potential applications for natural silk proteins stored inside the new capsules include the development of skin treatments for burns or cosmetic use, and the design of strong elastic fibers for tissue engineering – for example, for the fabrication of improved biological implants.
The research team included Dr. Simone F. Ruggeri, Dr. Erwin De Genst, Dr. Thomas Mueller, Dr. Teresa P. Barros, and Prof. Christopher M. Dobson of the University of Cambridge; Dr. Jozef Adamcik and Prof. Raffaele Mezzenga of ETH Zurich; Profs. David Porter and Fritz Vollrath of the University of Oxford; and Dr. Chris Holland of the University of Sheffield.
Dr. Ulyana Shimanovich’s research is supported by the Benoziyo Fund for the Advancement of Science; the Peter and Patricia Gruber Awards; and Georges Lustgarten.
